Abstract 634: SOX11 is a potential clinical marker for hormone receptor negative ductal carcinoma in situ

2018 ◽  
Author(s):  
Kazuharu Kai ◽  
Wei Lu ◽  
Fei Yang ◽  
Ximing Tang ◽  
Ignacio I. Wistuba ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Hormone Receptor ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Clinical Marker

scholarly journals Hormone Receptor Subtype in Ductal Carcinoma in Situ: Prognostic and Predictive Roles of the Progesterone Receptor

2021 ◽  
Author(s):  
Ki‐Tae Hwang ◽  
Young Jin Suh ◽  
Chan‐Heun Park ◽  
Young Joo Lee ◽  
Jee Ye Kim ◽  
...  
Keyword(s):  
Progesterone Receptor ◽  
Ductal Carcinoma In Situ ◽  
Hormone Receptor ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Receptor Subtype
Sign in / Sign up

Export Citation Format

Share Document